Friday, November 14, 2014 6:37:31 PM
Your not kidding, just check this alone out;
on page 22
Note 11- Liability for Conversion Feature of Preferred Shares
Upon the issuance of the Series B Preferred and the Series C Preferred for the Conexus Cattle acquisition (See Note 14 below), the owners of these securities were entitled to receive in total 95% of the common stock of the Company upon full conversion. Assuming full conversion, based on the common shares outstanding at the Balance Sheet date, there would be 47,747,371,030 shares, 37,747,371,030 more than the current authorized amount (and also not including the 2,387,368,552 currently outstanding either). Based on the stock price at September 30, 2014, $.0001, the total value of those shares would be $3,774,737. In accordance with Generally Accepted Accounting Principles, the Company recorded a liability for that amount on the Financial statements.
on page 23
We issued 6,500 shares of our Series B preferred stock to each of Stephen J. Price and Gerard Daignault for serving as officers and directors of our company??? and we issued 3,500 shares of our series C preferred stock to each of ASC Recap and Adirondack Partners LLC upon entering into consulting agreements with us???
See Note 11 above for the potential dilution and liability associated with the issuance of these shares.
Looks like the BRZG insiders (who have yet to do a thing) will really really need this R/S just to properly milk their shareholders for all they have already planned on getting for doing nothing.
North Bay Resources Commences Operations at Bishop Gold Mill, Inyo County, California; Engages Sabean Group Management Consulting • NBRI • Sep 25, 2024 9:15 AM
CEO David B. Dorwart Anticipates a Bright Future at Good Gaming Inc. Through His Most Recent Shareholder Update • GMER • Sep 25, 2024 8:30 AM
Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • BLOZF • Sep 24, 2024 8:50 AM
Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • INTV • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM